US Patent Issued to IOMX THERAPEUTICS on June 24 for "Intracellular kinase associated with resistance against anti-tumour immune responses, and uses thereof" (German Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,440, issued on June 24, was assigned to IOMX THERAPEUTICS AG (Martinsried, Germany).

"Intracellular kinase associated with resistance against anti-tumour immune responses, and uses thereof" was invented by Antonio Sorrentino (Heidelberg, Germany), Philipp Beckhove (Regensburg, Germany), Tillmann Michels (Heidelberg, Germany), Nisit Khandelwal (Martinsried, Germany), Michael Boutros (Heidelberg, Germany), Marco Breinig (Schriesheim, Germany), Peter Sennhenn (Martinsried, Germany), Sebastian Meier-Ewert (Martinsried, Germany), Valentina Volpin (Regensburg, Germany) and Ayse Nur Menevse (Regensburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office:...